Spironolactone
Product Images NDC 17856-2028

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Spironolactone (NDC 17856-2028). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Atlantic Biologicals Corp., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image Description (17856 2028 02)

Image Description (17856 2028 02)
The label for Carospir (Spironolactone) oral suspension, 25 mg per 5 mL, delivering 12.5 mg per 2.5 mL dose. It features dosing instructions, storage conditions including controlled room temperature guidelines, and cautions to keep medication out of reach of children. The package contains 10 enfit syringes and is distributed by Atlantic Biologicals Corp.*
FDA Label Image

Image Description (17856 2028 03)

Image Description (17856 2028 03)
Label for Carospir (Spironolactone) oral suspension, 25 mg per 5 mL, delivering 12.5 mg per 2.5 mL. The product is provided in a 60 Enfit Syringe package. Labeler and distributor is Atlantic Biologicals Corp. The label includes storage instructions, a barcode, QR code, expiration date, and RX designation.*
FDA Label Image

Structural Formula (Spironolactone Oral Suspension 1)

Structural Formula (Spironolactone Oral Suspension 1)
Chemical structure of spironolactone showing its molecular framework with cyclic rings and functional groups including a lactone ring and ketone groups.*
FDA Label Image

Figure 1 (Spironolactone Oral Suspension 2)

Figure 1 (Spironolactone Oral Suspension 2)
A survival curve chart titled 'Survival by Treatment Group in RALES' showing probability over time in months. Two groups are compared: Spironolactone (n=822) and Placebo (n=841), with Spironolactone showing a higher survival probability over approximately 48 months. The chart includes a statistical significance p-value of less than 0.001 by log-rank test.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.